Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Ascentage Pharma is discovering and developing small molecule drugs for the treatment of cancer that block or degrade protein targets implicated in cancer. It has active clinical programs targeting ...

Outsourcing to a contract development and manufacturing organization (CDMO) is a critical step for many biotech companies aiming to advance their programs without building costly internal ...

What are the causes of Parkinson’s disease and current therapeutic approaches? Although the underlying cause of Parkinson’s is unknown, scientists do know that the disease results from a loss of ...

With advanced therapies driving change across the pharmaceutical landscape, the EMEA region is seeing a rise in biotherapeutics development, specifically cell and gene therapies (CGTs). But as ...